Hypertonic Compositions for Ototoxicity Protection in Non-Cancer Applications

The present inventive concept expands the use of hypertonic pharmaceutical compositions containing an anti-platinum chemoprotectant agent to protect against ototoxicity in various non-cancer applications, including agriculture, environmental conservation, noise protection, wildlife conservation, and radiation therapy.

The original patent disclosed hypertonic pharmaceutical compositions containing an anti-platinum chemoprotectant agent for protecting against ototoxicity in cancer patients undergoing platinum-based chemotherapy. However, platinum-based compounds are also used in other industries, such as agriculture, environmental conservation, and radiation therapy, where they can cause ototoxicity in humans, animals, and aquatic organisms. The present inventive concept addresses this limitation by applying the core technology to these new fields, providing a solution to the unmet need of protecting against ototoxicity in these contexts.

The inventive concept comprises hypertonic pharmaceutical compositions containing an anti-platinum chemoprotectant agent, which can be applied to various non-cancer applications. For example, in agriculture, the composition can be used to protect crops from platinum-based pesticide-induced ototoxicity. In environmental conservation, the composition can be administered to aquatic organisms exposed to platinum-based pollutants to reduce environmental toxicity. In noise protection, the composition can be used to protect individuals from noise-induced hearing loss. In wildlife conservation, the composition can be used to treat platinum-based metal poisoning in animals. In radiation therapy, the composition can be co-administered with platinum-based radiation therapy to reduce ototoxicity in patients.

The new claims introduce novel applications of the hypertonic pharmaceutical compositions containing an anti-platinum chemoprotectant agent, which were not contemplated in the original patent. The inventive step lies in the recognition of the potential of the core technology to address ototoxicity in various non-cancer applications, and the development of new compositions and methods tailored to these specific fields.

Alternative embodiments of the inventive concept may include different formulations of the hypertonic composition, such as topical or oral administration, or the use of different anti-platinum chemoprotectant agents. Variations of the inventive concept may include the use of the hypertonic composition in combination with other protective agents or therapies to enhance its effectiveness.

The inventive concept has significant commercial potential in various industries, including agriculture, environmental conservation, noise protection, wildlife conservation, and radiation therapy. The market for ototoxicity protection is substantial, and the inventive concept offers a unique solution to address this unmet need.